Insider Stock Trading History of Ratcliffe Liam


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ratcliffe Liam since year 2005. The trader's CIK number is 1547100. At the time of this reporting, Ratcliffe Liam is the Director of Deciphera Pharmaceuticals, Inc. . (stock ticker symbol DCPH). See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .

Note that in the past Ratcliffe Liam also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ratcliffe Liam since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 DCPH Deciphera Pharmaceuticals, Inc. Buy 375,000 17.00 6,375,000
2015-03-24 MEIP Marshall Edwards Inc Sale 1,601,390 1.97 3,159,542
2014-12-18 VSAR Versartis, Inc. Sale 150,000 19.01 2,851,800
2014-12-08 MEIP Marshall Edwards Inc Sale 9,004 6.05 54,492
2014-12-09 MEIP Marshall Edwards Inc Sale 70,081 6.01 421,116
2014-11-11 VSAR Versartis, Inc. Sale 800,000 19.37 15,496,000
2014-09-29 VSAR Versartis, Inc. Sale 12,556 20.02 251,333
2014-03-27 VSAR Versartis, Inc. Buy 60,000 21.02 1,261,200
2013-11-21 MEIP Marshall Edwards Inc Sale 365,000 8.25 3,011,250
2013-11-20 RLYP Relypsa Inc Buy 185,978 11.00 2,045,758
2013-11-20 RLYP Relypsa Inc Option Ex 25,977 9.19 238,598
2013-09-26 ARRY Array Biopharma Inc Sale 262,207 6.02 1,579,010
2013-09-27 ARRY Array Biopharma Inc Sale 863,521 5.99 5,170,763
2013-09-12 ARRY Array Biopharma Inc Sale 807,479 6.10 4,923,199
2013-09-13 ARRY Array Biopharma Inc Sale 546,660 6.01 3,287,613
2013-09-16 ARRY Array Biopharma Inc Sale 319,033 6.14 1,957,586
2013-09-04 ARRY Array Biopharma Inc Sale 236,116 5.87 1,385,528
2013-09-05 ARRY Array Biopharma Inc Sale 201,598 5.77 1,163,422
2013-09-06 ARRY Array Biopharma Inc Sale 139,572 5.68 793,187

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ratcliffe Liam (Director of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.